Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Conformal SiNx Coating on Carbon Nanotubes via Transient UV-Ozone Functionalization and Two-Step Atomic Layer Deposition.

Materials (Basel, Switzerland)·2026
Same author

Harnessing Cancer Stem Cells and 3D Organoids in Unravelling Spatial and Cellular Heterogeneity in Cancer.

International journal of molecular sciences·2026
Same author

Intensified water column hypoxia drives disproportionate benthic P release and N:P imbalance via enhanced sedimentary sulfate reduction.

Marine pollution bulletin·2026
Same author

Connector-enabled integration of Golden Gate Assembly and yeast recombination for streamlined multigene pathway construction in the biofoundry workflow.

Trends in biotechnology·2026
Same author

Hole-Patterned Pellicles: A Structural Approach for Improved Extreme Ultraviolet Transmittance and Mechanical Behavior.

Materials (Basel, Switzerland)·2026
Same author

Compliance and Satisfaction for 16 months of Adapted Tango vs. Supervised Walking for People with Parkinson's.

NPJ Parkinson's disease·2025

相关实验视频

Updated: May 9, 2026

Solid Lipid Nanoparticles SLNs for Intracellular Targeting Applications
08:19

Solid Lipid Nanoparticles SLNs for Intracellular Targeting Applications

Published on: November 17, 2015

17.8K

装有4-hexylresorcinol的固体脂质纳米粒子用于增强抗癌活性.

Sooho Yeo1, Sukkyun Jung2, Haneul Kim1

  • 1Yonsei Institute of Pharmaceutical Sciences, College of Pharmacy, Yonsei University, Incheon 21983, Republic of Korea.

Pharmaceuticals (Basel, Switzerland)
|October 26, 2024
PubMed
概括

固体脂质纳米颗粒 (SLN) 有效地输送了4-hexylresorcinol (4-HR),用于增强癌症化疗. 封装改善了药物吸收和抗癌作用,显示了瘤治疗的前景.

关键词:
4 - 基复合素醇抗癌疗法是一种抗癌治疗.化学疗法 化疗 化疗增强了透和保留效应.固体脂质纳米粒子是一种固体脂质纳米粒子.

更多相关视频

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier
07:53

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier

Published on: April 26, 2016

11.1K
Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells
09:34

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells

Published on: February 9, 2019

8.9K

相关实验视频

Last Updated: May 9, 2026

Solid Lipid Nanoparticles SLNs for Intracellular Targeting Applications
08:19

Solid Lipid Nanoparticles SLNs for Intracellular Targeting Applications

Published on: November 17, 2015

17.8K
Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier
07:53

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier

Published on: April 26, 2016

11.1K
Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells
09:34

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells

Published on: February 9, 2019

8.9K

科学领域:

  • 纳米技术在医学中的应用
  • 药物输送系统 药物输送系统
  • 癌症治疗方法 癌症治疗方法

背景情况:

  • 癌症仍然是全球主要的健康威胁,需要在手术后采取先进的化疗策略.
  • 4-hexylresorcinol (4-HR) 具有抗癌特性,但由于聚合,在向的输送和细胞吸收方面面临挑战.
  • 固体脂质纳米颗粒 (SLN) 为克服这些局限性提供了一个潜在的解决方案.

研究的目的:

  • 用于将4-hexylresorcinol (4-HR) 封装成固体脂质纳米粒子 (SLN).
  • 通过改善其向传递和细胞吸收来增强4-HR的抗癌疗效.
  • 为了减轻与生物系统中的4-HR相关的聚合问题.

主要方法:

  • 用4-HR装载的SLN是使用热同质化和超声波制造的.
  • 鉴定包括分析颗粒大小,泽塔潜力和药物释放动力学.
  • 在实验室中对人类宫 (HeLa),肺 (A549) 和小鼠结肠 (CT-26) 癌细胞系进行了细胞毒性评估.

主要成果:

  • SLN粒子大小在169.4至644.8纳米之间,泽塔电位在19.8至-40.3mV之间,表明它适合细胞吸收.
  • 4-HR的高捕获效率 (EE) 从75.0%到96.5%不等.
  • 与自由的4-HR相比,带有4-HR的SLN显著增加了细胞毒性,有效性取决于颗粒大小,EE和细胞类型.

结论:

  • 4-HR载荷的SLN代表了改善化疗结果的有希望的纳米载体系统.
  • 这种配方策略有效地增强了4-hexylresorcinol的抗癌潜力.
  • SLN封装为克服癌症治疗中药物输送挑战提供了一种可行的方法.